Labcorp Holdings (BSP:L1CA34) Cyclically Adjusted FCF per Share: R$18.83 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:L1CA34 Labcorp Holdings Inc BSP:L1CA34
64 GF Score
Price R$374.88
GF Value R$304.58
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Labcorp Holdings Cyclically Adjusted FCF per Share?

Labcorp Holdings BSP:L1CA34 64 Cyclically Adjusted FCF per Share is R$18.83 as of Jun. 2026. GuruFocus rates BSP:L1CA34 with a GF Score™ of 64/100 and a GF Value™ of R$304.58 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Labcorp Holdings's adjusted free cash flow per share for the three months ended in Jun. 2026 was R$4.904. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$18.83 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Labcorp Holdings's average Cyclically Adjusted FCF Growth Rate was 5.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 5.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Labcorp Holdings was 53.70% per year. The lowest was -7.20% per year. And the median was 8.80% per year.

As of today (2026-08-28), Labcorp Holdings's current stock price is R$374.88. Labcorp Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was R$18.83. Labcorp Holdings's Cyclically Adjusted Price-to-FCF of today is 19.91.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Labcorp Holdings was 23.33. The lowest was 10.59. And the median was 16.80.


Labcorp Holdings  (BSP:L1CA34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Labcorp Holdings's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=374.88/18.83
=19.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Labcorp Holdings was 23.33. The lowest was 10.59. And the median was 16.80.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Labcorp Holdings Cyclically Adjusted FCF per Share Related Terms


Labcorp Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings Cyclically Adjusted FCF per Share Chart

Labcorp Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.20 21.45 17.67 20.91 23.43

Labcorp Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.04 21.31 23.43 22.48 18.83

BSP:L1CA34 vs DGX, MTD, GH: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Labcorp Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Cyclically Adjusted Price-to-FCF falls into.


BSP:L1CA34
64GF Score
Labcorp Holdings Inc BSP:L1CA34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labcorp Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Labcorp Holdings's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.904/333.9520*333.9520
=4.904

Current CPI (Jun. 2026) = 333.9520.

Labcorp Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 1.424 241.428 1.970
201612 3.173 241.432 4.389
201703 1.143 243.801 1.566
201706 1.907 244.955 2.600
201709 2.427 246.819 3.284
201712 3.716 246.524 5.034
201803 0.850 249.554 1.137
201806 2.748 251.989 3.642
201809 1.540 252.439 2.037
201812 3.497 251.233 4.648
201903 0.691 254.202 0.908
201906 1.642 256.143 2.141
201909 3.803 256.759 4.946
201912 4.624 256.974 6.009
202003 1.222 258.115 1.581
202006 3.614 257.797 4.682
202009 9.757 260.280 12.519
202012 8.834 260.474 11.326
202103 15.192 264.877 19.154
202106 4.993 271.696 6.137
202109 8.828 274.310 10.747
202112 8.609 278.802 10.312
202203 3.161 287.504 3.672
202206 6.024 296.311 6.789
202209 4.206 296.808 4.732
202212 8.152 296.797 9.173
202303 0.629 301.836 0.696
202306 3.383 305.109 3.703
202309 2.421 307.789 2.627
202312 5.908 306.746 6.432
202403 -2.405 312.332 -2.571
202406 6.915 314.175 7.350
202409 2.649 315.301 2.806
202412 12.062 315.605 12.763
202503 -1.836 319.799 -1.917
202506 8.968 322.561 9.285
202509 4.493 324.800 4.620
202512 8.038 324.054 8.284
202603 1.112 330.213 1.125
202606 4.904 333.952 4.904

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$18.83 mean?
Labcorp Holdings (BSP:L1CA34) has a Cyclically Adjusted FCF per Share of R$18.83 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Labcorp Holdings and its competitors.
Is Labcorp Holdings' Cyclically Adjusted FCF per Share too high?
Labcorp Holdings' current Cyclically Adjusted FCF per Share is R$18.83. Overall, Labcorp Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Cyclically Adjusted FCF per Share compare to DGX and MTD?
Labcorp Holdings' Cyclically Adjusted FCF per Share of R$18.83 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Cyclically Adjusted FCF per Share is R$18.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (BSP:L1CA34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$304.58, compared to a current price of R$374.88 — trading 23.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is R$18.83. Labcorp Holdings' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Labcorp Holdings (BSP:L1CA34), the current Cyclically Adjusted FCF per Share is R$18.83 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (BSP:L1CA34) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of R$374.88 is trading 23.1% above its estimated GF Value™ of R$304.58. GuruFocus considers Labcorp Holdings to be Modestly Overvalued.

Key valuation signals for BSP:L1CA34:

  • Cyclically Adjusted FCF per Share: R$18.83
  • GF Value™: R$304.58 vs. price of R$374.88 (23.1% above fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the BSP:L1CA34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labcorp Holdings Business Description

Other Exchanges LH:USA0JSY:UKN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
64GF Score

Get the complete analysis for BSP:L1CA34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$374.88
Price
R$304.58
GF Value